Chemotherapy Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes May 19, 2023
Special Populations Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing March 10, 2023
Oncology nurse education Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care January 13, 2023
Pancreatic cancer Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results November 11, 2022
Trending Topics Research Treatments Safety COVID-19 Drug Reference Sheet Special Populations View All Topics
U.S. Food and Drug Administration (FDA) FDA Approves Dabrafenib With Trametinib for Pediatric Patients With Low-Grade Glioma and a BRAF V600E Variant March 20, 2023
Special Populations RNs Need More Education About Reasonable Accommodations for Patients With Intellectual Disabilities March 15, 2023
Research Four R’s and Resilience Approach Help Oncology Nurses Respond to Morally Distressing Challenges March 14, 2023
U.S. Food and Drug Administration (FDA) FDA Expands Early Breast Cancer Indication for Abemaciclib With Endocrine Therapy March 07, 2023
Oncology nurse education Gamification Helps Oncology Nurses Retain Their Cancer Knowledge and Best Practices March 01, 2023
Patient empowerment Tip Sheet Helps Nurses Confront Systemic Racism by Providing Equitable Hair Care February 22, 2023
Clinical practice Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment February 15, 2023
U.S. Food and Drug Administration (FDA) FDA Grants Regular Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer February 10, 2023
Press Releases Rejuvenate, Refocus, and Revitalize Your Practice and Yourself at the 48th Annual ONS Congress® February 10, 2023
Advanced Practice Nursing (APRN) Oncology Providers Can Transform the Trajectory of Financial Toxicity February 09, 2023
Research Nearly 25% of Patients With Cancer Are Victims of Intimate Partner Violence February 08, 2023
U.S. Food and Drug Administration (FDA) Smiths Medical Recalls More Than 19 Million CADD System Administration Sets and Cassette Reservoirs Because of Medication Delivery Issues February 07, 2023
Culture of safety How Nurses and Administrators Can Respond to the Prevalence of Violence in Health Care February 07, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Sacituzumab Govitecan-Hziy for HR-Positive Breast Cancer February 06, 2023
Patient Education Use Motivational Interviewing to Tailor Your Conversations to Your Patients’ Unique Needs February 02, 2023
Special Populations Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options February 01, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Elacestrant for ER-Positive, HER2-Negative, ESR1-Variant Advanced or Metastatic Breast Cancer January 31, 2023
Nurse well-being Mentorships Open Opportunities for Oncology Nurses’ Career Growth and Wellness January 31, 2023
U.S. Food and Drug Administration (FDA) Focus on COVID-19 Prevention Intensifies for Patients With Cancer as FDA Removes Emergency Use Authorization for Evushield January 30, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer January 30, 2023
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma January 30, 2023
Pancreatic cancer Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes January 25, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma January 20, 2023
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tucatinib With Trastuzumab for Colorectal Cancer January 20, 2023
U.S. Food and Drug Administration (FDA) Smiths Medical Issues Urgent Medical Device Correction Letter About Potential Issues With CADD™ Infusion Sets January 12, 2023
U.S. Food and Drug Administration (FDA) Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration January 12, 2023
Adverse events Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities January 11, 2023
Special Populations Achieve Equity in Patient Communication With These Evidence-Based Approaches January 10, 2023
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Mosunetuzumab-Axgb for Relapsed or Refractory Follicular Lymphoma January 06, 2023
Special Populations Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment January 05, 2023
U.S. Food and Drug Administration (FDA) Hospira, Inc., Issues Voluntary Nationwide Recall for One Lot of Vancomycin Hydrochloride Injection, USP 1.5 g January 04, 2023